Bimarsh Acharya

Dr. Bimarsh Acharya

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2023 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
BJBhaskar Jha
Bhaskar Jha
AJApurwa Jha
Apurwa Jha
SKShailendra Karki
Shailendra Karki
PKPooja Kc
Pooja Kc
APAnish Pandey
Anish Pandey
BABimarsh Acharya
Bimarsh Acharya
Introduction: Mad honey consumption is a common practice in Nepal for medicinal and consumption purposes, but it can lead to severe adverse effects. Grayanotoxin I and Grayanotoxin III isoforms found in rhododendron interfere with voltage-gated sodium channels resulting in gastrointestinal symptoms, and cardiovascular effects such as low blood pressure, abnormal heart rhythms, cardiac arrest, and abnormal electrical conduction in the heart, as well as rare central nervous system disorders. Here the authors report a case of Mad honey consumption leading to anaphylactic shock along with its investigations and management. Case presentation: The authors present a case of a 51-year-old female who developed anaphylactic shock after consuming mad honey. The patient experienced symptoms including nausea, vomiting, abdominal pain, sweating, dizziness, facial and lip swelling, but no chest pain, loss of consciousness, abnormal body movement, or dyspnoea. The patient had no prior medical conditions, regular medications, or history of allergic reactions to honey or pollen. Discussion: Mad honey intoxication is caused by grayanotoxins, with distinct cardiac effects for different types of grayanotoxins. Symptoms include bradycardia, hypotension, abdominal pain, dizziness, and nausea, which subsided within 24 h following the initial management. The presence of grayanotoxin can be detected using specialized instrumentation, but it may not be available in all medical facilities. Co-intoxication with alcohol or propolis may also occur. Conclusion: This case highlights the importance of recognizing and managing complications associated with mad honey consumption, particularly in regions where it is prevalent. Prompt medical attention is advised if unusual symptoms occur after honey consumption.

17 February 2023 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
BABimarsh Acharya
Bimarsh Acharya
SKSabin Mbbs Kc
Sabin Mbbs Kc
SKShailendra Mbbs Karki
Shailendra Mbbs Karki
PTPratima Mbbs Thapa
Pratima Mbbs Thapa
PKPooja Mbbs Kc
Pooja Mbbs Kc
Introduction and Importance: Guillain-Barré syndrome (GBS) is a rare acute idiopathic demyelinating polyneuropathy that causes bilateral, symmetrical, and progressive weakness of muscles. AstraZeneca vaccine is a genetically modified spike glycoprotein vaccine of an adenovirus vector. GBS following the second dose of the AstraZeneca vaccine dose is rare and not frequently noted. Case Presentation: A 78-year-old male presented to the hospital with complaints of bilateral weakness of the lower limbs over 4 days following the second dose of the AstraZeneca vaccine. On examination, the power and tone of the limbs were diminished. The sensitivity pinprick test revealed low sensitivity in the right lower limb than in the left lower limb. Nerve conduction studies revealed acute inflammatory demyelinating polyneuropathy and the patient was diagnosed with GBS. After admission, the patient was successfully treated with intravenous immunoglobulins along with physiotherapy. Clinical Discussion: GBS can be diagnosed clinically with nerve conduction studies and Brighton’s criteria. The robust causal relationships between COVID-19 infections, COVID-19 vaccination, and GBS are still unclear. The evaluation of the potential association and risk of GBS with vaccines warrants the need for precise post-vaccination surveillance measures and results. Conclusion: Only a few cases of GBS following the second dose of AstraZeneca are reported so far and there is a need for strong and accurate diagnosis of the disease and proper post-vaccination surveillance for the evaluation of risk associated with COVID vaccines.

1 January 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
MJMandeep D. Mbbs Joshi
Mandeep D. Mbbs Joshi
BABimarsh Acharya
Bimarsh Acharya
SSSurendra Mbbs Sapkota
Surendra Mbbs Sapkota
KKKaruna Mbbs Khati
Karuna Mbbs Khati
DDDissanayake M. L. Mbbs Randuwini Dissanayake
Dissanayake M. L. Mbbs Randuwini Dissanayake
JJJayanti Jawarchan
Jayanti Jawarchan
Introduction and importance: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are the severe adverse drug reactions following drugs like carbamazepine, allopurinol, and infections. Here we present A 32-year-old woman developed SJS/TEN after 7 days of carbamazepine therapy, highlighting the importance of recognizing this risk, particularly in HLA-B*1502 allele carriers. Case presentation: A 32-year-old female developed fever, vomiting, and mucocutaneous blisters 7 days after starting carbamazepine. Lesions spread from the face to the chest, abdomen, and extremities, with throat discomfort and eye discharge. History included prior dizziness episodes. Examination revealed denuded skin, positive Nikolsky’s sign, and HLA-B*1502 allele positivity. Treatment comprised ceasing carbamazepine, fluid administration, and steroids. Discussion: SJS/TEN manifest with distinct symptoms and often emerge within weeks of drug exposure. Carbamazepine, a frequent trigger, poses higher risks for HLA-B1502 allele carriers. Timely identification and intervention are essential to reduce mortality rates (10-40%). Treatment involves corticosteroids and supportive measures, with pre-carbamazepine HLA-B1502 screening advised, despite potential accessibility constraints. Conclusion: This case underscores the necessity of recognizing carbamazepine-induced SJS/TEN risk, particularly in HLA-B*1502 carriers. Despite screening challenges, early intervention involving multidisciplinary specialists is essential for favorable outcomes. Increased awareness and proactive measures are vital in preventing and managing these severe reactions.

29 September 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
DYDipesh Kumar Yadav
Dipesh Kumar Yadav
UGUzka Ghayour
Uzka Ghayour
BABimarsh Acharya
Bimarsh Acharya
AAAbdul Sattar Anjum
Abdul Sattar Anjum
MWMunna William
Munna William
SASadia Anjum
Sadia Anjum
Introduction: Gestational choriocarcinoma is a malignant subtype of gestational trophoblastic neoplasia (GTN) characterized by rapid hematogenous spread, commonly affecting the lungs, brain, liver, and pelvis. However, renal metastasis, particularly bilateral, further complicated by spontaneous retroperitoneal hemorrhage (SRH), is exceedingly rare and poses significant diagnostic and therapeutic challenges. Case presentation: This case report describes a 33-year-old woman who presented with a 15-day history of progressive shortness of breath, vaginal bleeding, and flank pain, occurring 4 years after a term pregnancy. Investigations revealed severe anemia, markedly elevated beta-hCG, and metastatic lesions in the lungs, brain, and bilateral kidneys with significant retroperitoneal hemorrhage. Despite prompt resuscitation and initiation of EMA/CO chemotherapy, the patient’s condition deteriorated rapidly due to hemorrhagic brain metastases, and she succumbed to intracranial complications resulting from hemorrhagic brain metastases. Discussion: This case illustrates the aggressive nature of choriocarcinoma, which can arise years after childbirth without uterine involvement. Bilateral renal metastases with SRH are uncommon, complicating diagnosis and treatment, whereas hemorrhagic brain lesions emphasize the disease’s severity. Persistently high beta-hCG continues to be a crucial indicator for diagnosis. Conclusion: This report highlights a rare case of gestational choriocarcinoma with extensive metastasis presenting years after a post-term pregnancy. Early suspicion and aggressive treatment are crucial, though prognosis is poor in advanced, treatment-resistant cases. Routine beta-hCG monitoring in postpartum women with unexplained symptoms may enable earlier detection and timely intervention.

17 November 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
BPBijay Panday
Bijay Panday
RDRojan Singh Dangol
Rojan Singh Dangol
MJMandeep Dutta Joshi
Mandeep Dutta Joshi
BABimarsh Acharya
Bimarsh Acharya
SBSunil Man Bijukchhe
Sunil Man Bijukchhe
BNBhoj Raj Neupane
Bhoj Raj Neupane
Introduction and Importance: Double gallbladder is a rare congenital anomaly occurring in 1 in 4000 births, often found incidentally during surgery. It is classified by Boyden into bilobed gallbladder with a single cystic duct (vesica fellea divisa) or true duplication with separate cystic ducts (vesica fellea duplex). Case Presentation: A 50-year-old male presented with intermittent right upper quadrant abdominal pain for 2 months. Examination revealed icteric sclera and deranged liver function tests. Ultrasonography showed a contracted gallbladder with a dilated common bile duct and a calculus. Magnetic resonance cholangiopancreatography (MRCP) confirmed a V-shaped double gallbladder with a single common cystic duct and filling defect. After treating a concurrent chest infection, laparoscopic cholecystectomy was performed. Intraoperatively, two gallbladders connected by a common cystic duct were found, with a stone in the intrahepatic gallbladder. The postoperative period was uneventful. Clinical Discussion: Duplicated gallbladder is a rare anatomical variant that can present diagnostic challenges. MRCP is the preferred noninvasive imaging technique for accurate preoperative identification and surgical planning. Laparoscopic cholecystectomy is the treatment of choice in symptomatic cases, with intraoperative cholangiography as an adjunct when diagnosis is unclear. Proper anatomical mapping is essential to prevent complications such as bile duct injury and hemorrhage. Conclusion: Accurate diagnosis and careful surgical planning are critical in managing double gallbladder cases to avoid iatrogenic injuries. This case highlights the importance of using MRCP and intraoperative cholangiogram for optimal outcomes and adds valuable regional data on this rare anomaly.

1 July 2024 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
NPNikhil Puduru
Nikhil Puduru
DKDilip Vasant Dnb Ka
Dilip Vasant Dnb Ka
FSFaiza A. Shaikh
Faiza A. Shaikh
HSHumaira Mbbs Shaikh
Humaira Mbbs Shaikh
BABimarsh Acharya
Bimarsh Acharya
PSPishoy Mbbs Sydhom
Pishoy Mbbs Sydhom
Introduction and importance: Hamartomas are abnormal growths that consist of various types of mesenchymal tissues, including cartilage, fat, connective tissue, and smooth muscle. These tumors can occur in almost any organ system within the body. While head and neck hamartomas have been frequently documented, cases involving the lower limbs are relatively rare. However, a unique instance of a mesenchymal hamartoma located in the leg has recently emerged. Case presentation: A 30-year-old woman presented with a painless, gradually growing swelling on her left leg, diagnosed as a subcutaneous hemangioma preoperatively. Despite unsuccessful propranolol treatment, surgical excision revealed a mesenchymal hamartoma. Postoperative examination confirmed the diagnosis, and the patient recovered smoothly without recurrence after a week of hospitalization. Clinical discussion: Cutaneous mesenchymal hamartomas are benign tissue growths with unknown etiology, associated with syndromes like Cowden and Peutz-Jeghers. Smooth muscle hamartoma can be acquired after skin trauma. Hemartoma can be misdiagnosed as hemangiomas. Cutaneous mesenchymal hamartomas presents as painless swellings in various locations, occasionally in adulthood. Differential diagnoses include lipomas and fibromas. Surgical excision is recommended for symptomatic cases to prevent recurrence. Conclusion: This case highlights the atypical presentation of the hamartoma and emphasizes the importance of accurate diagnosis and management.